TMS Basics

TMS = Transcranial Magnetic Stimulation

TMS is FDA Approved for Treatment of Major Depressive Disorder.

Completely non-invasive treatment for depression with minimal side effects & no recovery time.

Timed pulses of an MRI-strength magnet targeted to specific, mapped, sites on a patient’s head related to mood regulation.

Magnetic pulses stimulate neuroconnections on the left side of the brain that become less active in the brain of a depressed person.

Treatments stimulate the neuroconnectors, leading to increased activity & symptom reduction. (Please see included PET scan illustrating brain activity before & after TMS). Average treatment schedule & duration: 5 days/week; 45 minutes/day; 12 weeks.

TMS has an average response rate of greater 70% & remission rate greater than 50% when augmenting a current medication regimen with TMS.

PET Scan in Depressed Patient

The glowing parts of the image display brain activity.

Depressed brains show decreased activity in the left brain. TMS treats depression by stimulating the neuroconnectors using magnetic pulses targeted to a specific site on the head.

Scan of brain showing before and after TMS treatment.


Does insurance cover TMS treatments?

Yes. Most commercial insurance plans and some Medicare Advantage plans cover TMS, although there is variance in the amount of coverage.

What are the side effects of TMS?

Side effects from TMS treatments are minimal & rare. Occasionally, a patient may experience tenderness at the treatment site. Rarely, a patient may experience a slight headache after treatment.

Who is a good candidate for TMS Treatment?

Anyone suffering from Treatment-Resistant Depression. Those most likely to be pre-authorized for TMS treatments by insurance companies are people who have tried more than 3 pharmaceutical interventions in more than 1 class.

How are patients monitored during TMS treatments?

All potential TMS patients are first evaluated by one of our psychiatric providers. Once approved for treatment, patients’ progress is consistently monitored by an evidence-based depression scale administered by a Psychiatric Solutions provider.